1.Monitoring Changes in Hepatic Venous Velocities Flow after a Fluid Challenge Can Identify Shock Patients Who Lack Fluid Responsiveness.
Wei DU ; Xiao-Ting WANG ; Yun LONG ; Da-Wei LIU
Chinese Medical Journal 2017;130(10):1202-1210
BACKGROUNDEvaluating the hemodynamic status and predicting fluid responsiveness are important in critical ultrasound assessment of shock patients. Transthoracic echocardiography with noninvasive diagnostic parameters allows the assessment of volume responsiveness. This study aimed to assess the hemodynamic changes in the liver and systemic hemodynamic changes during fluid challenge and during passive leg raising (PLR) by measuring hepatic venous flow (HVF) velocity.
METHODSThis is an open-label study in a tertiary teaching hospital. Shock patients with hypoperfusion who required fluid challenge were selected for the study. Patients <18 years old and those with contraindications to PLR were excluded from the study. Baseline values were measured, PLR tests were performed, and 500 ml of saline was infused over 30 min. Parameters associated with cardiac output (CO) in the left ventricular outflow tract were measured using the Doppler method. In addition, HVF velocity and right ventricular function parameters were determined.
RESULTSMiddle hepatic venous (MHV) S-wave velocity was positively correlated in all patients with CO at baseline (r = 0.706, P< 0.01) and after volume expansion (r = 0.524, P= 0.003). CO was also significantly correlated with MHV S-wave velocity in responders (r = 0.608, P< 0.01). During PLR, however, hepatic venous S-wave velocity did not correlate with CO. For the parameter ΔMHV D (increase in change in MHV D-wave velocity after volume expansion), defined as (MHV DafterVE - MHV DBaseline)/MHV DBaseline× 100%, >21% indicated no fluid responsiveness, with a sensitivity of 100%, a specificity of 71.2%, and an area under the receiver operating characteristic curve of 0.918.
CONCLUSIONSDuring fluid expansion, hepatic venous S-wave velocity can be used to monitor CO, whether or not it is increasing. ΔMHV D ≥21% indicated a lack of fluid responsiveness, thus helping to decide when to stop infusions.
Aged ; Blood Pressure ; physiology ; Cardiac Output ; physiology ; Echocardiography ; Female ; Fluid Therapy ; Hemodynamics ; physiology ; Hepatic Veins ; physiology ; Humans ; Male ; Middle Aged ; Monitoring, Physiologic ; methods ; Portal Vein ; physiology ; ROC Curve ; Shock ; physiopathology ; Stroke Volume ; physiology
2.Maternal hepatic venous hemodynamics and cardiac output in normal and fetal growth restricted pregnancies.
Haiqin LIAO ; Dan ZHOU ; Kui TANG ; Minzhi OUYANG ; Xiaofang WANG ; Ming ZHANG
Journal of Central South University(Medical Sciences) 2018;43(9):987-993
To evaluate relationship of maternal hepatic vein Doppler flow parameters and cardiac output (CO) with neonatal birth weight in uncomplicated pregnancies (UP) and pregnancies complicated by fetal growth restriction (FGR) .
Methods: Hepatic vein impedance index (HVI), venous pulse transit time (VPTT), and CO were measured in women with UP at the 14th-37th weeks and complicated by FGR at the 26th-37th weeks who underwent maternal hepatic hemodynamic and echocardiographic examination during the ultrasonography. After delivery, the birth weight and the birth weight percentile of each neonate in this study were recorded. Correlations among HVI, VPTT, and CO were analyzed.
Results: In the UP group, HVI, VPTT, and CO changed with the increase of gestation. In the FGR group, HVI was higher, VPTT was shorter, CO and neonatal birth weight were obviously lower than those in the UP at the 26th-37th weeks (P<0.05).
Conclusion: There is a series of adaptive changes in hepatic venous hemodynamics and CO in UP with the increase of gestation to meet the demand of fetal growth, while the maladaptive changes in hepatic venous hemodynamics and CO in pregnant woman may contribute to FGR.
Birth Weight
;
Cardiac Output
;
Female
;
Fetal Development
;
physiology
;
Fetal Growth Retardation
;
physiopathology
;
Hemodynamics
;
physiology
;
Hepatic Veins
;
physiopathology
;
Humans
;
Infant, Newborn
;
Pregnancy
;
Ultrasonography, Prenatal
3.Hepatic venous pressure gradient: clinical use in chronic liver disease.
Clinical and Molecular Hepatology 2014;20(1):6-14
Portal hypertension is a severe consequence of chronic liver diseases and is responsible for the main clinical complications of liver cirrhosis. Hepatic venous pressure gradient (HVPG) measurement is the best available method to evaluate the presence and severity of portal hypertension. Clinically significant portal hypertension is defined as an increase in HVPG to >10 mmHg. In this condition, the complications of portal hypertension might begin to appear. HVPG measurement is increasingly used in the clinical fields, and the HVPG is a robust surrogate marker in many clinical applications such as diagnosis, risk stratification, identification of patients with hepatocellular carcinoma who are candidates for liver resection, monitoring of the efficacy of medical treatment, and assessment of progression of portal hypertension. Patients who had a reduction in HVPG of > or =20% or to < or =12 mmHg in response to drug therapy are defined as responders. Responders have a markedly decreased risk of bleeding/rebleeding, ascites, and spontaneous bacterial peritonitis, which results in improved survival. This review provides clinical use of HVPG measurement in the field of liver disease.
Chronic Disease
;
Hemodynamics
;
Hemorrhage/etiology
;
Hepatic Veins/physiology
;
Humans
;
Hypertension, Portal/complications
;
Liver Cirrhosis/diagnosis
;
Liver Diseases/complications/*physiopathology
;
Portal Pressure
4.Management of the middle hepatic vein in right lobe living donor liver transplantation: A meta-analysis.
Peng-Sheng YI ; Ming ZHANG ; Ming-Qing XU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(4):600-605
Living donor liver transplantation (LDLT) is a curative treatment for end stage liver disease. It is advantageous due to the shortage of deceased donors. However, in LDLT, whether the middle hepatic vein (MHV) should be preserved in donors remains controversial. We conducted searches in Pubmed, Embase, Cochrane Library, Web of Science, Ovid, and Google Scholar using the key words "living donor liver transplantation" and "middle hepatic vein". Due to ethical issues, there were no randomized control trails focusing on MHV in LDLT. The majority of reports were retrospective studies. We examined the reference lists to identify related investigations. Google Scholar was then used to obtain full texts. Nine observational studies were analyzed. There were no significant differences in liver function (WMD, -5.51; P=0.12) and complications (RR, 0.98; P=0.89) in donors with or without MHV. However, the liver function in recipients was greatly improved after LDLT with MHV (WMD, -78.32; P=0.01). No definite conclusion was obtained in terms of the liver regeneration indices between LDLT with or without MHV. It was conclude that grafts with MHV in LDLT favor recipient outcomes and do not harm the living donor if a careful preoperative evaluation is performed.
Adult
;
Databases, Bibliographic
;
Female
;
Graft Survival
;
Hepatic Veins
;
surgery
;
Humans
;
Liver
;
blood supply
;
physiology
;
Liver Transplantation
;
Living Donors
;
Male
;
Middle Aged
;
Observational Studies as Topic
;
Prognosis
5.Effect on Regenerating Capacity of Transplanted Liver by Arterialized Native Liver in Auxiliary Heterotopic Liver Transplantation in Pig.
Hyuk Joon LEE ; Hye Rin ROH ; Kyung Suk SUH ; Kuhn Uk LEE
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2002;6(1):20-25
BACKGROUND/AIMS: Auxiliary liver transplantation means a procedure in which part of the native liver is left in situ. In this method, it has been suggested that blocking of portal flow to the native liver (arterialized liver) could potentiate the regeneration of the graft liver. In this study, we evaluate the effect on regeneration capacity of graft liver by blocking the portal flow to the native liver in auxiliary heterotopic liver transplantation in pig. METHODS: Female pigs weighing 25 kg and 30 kg were used as the donor and the recipient for liver transplantation, respectively. After total hepatectomy in the donor pig, graft liver was placed inferior to right liver and superior to right kidney of the recipient. The donor's hepatic vein was anastomosed to infrahepatic inferior vena cava superior to renal vein. The portal vein of the recipient was divided at the hilum and anastomosed with donor's portal vein. The donor's hepatic artery was anastomosed to the aorta below the renal artery. After 1, 3, 5, 7, 15th postoperative days, the weights of native and graft liver, proliferative cell nuclear antigen (PCNA) indices of both livers, and liver function test were checked. RESULTS: During the procedure, hemodynamic status was stable without using venovenous bypass. There was no postoperative death and no severe deterioration of hepatic function. During 5th and 15th postoperative days, PCNA indices of graft liver (40~60%) were higher than those of native liver (30%). The weight of graft liver was increased more than 80% of preoperative value on day 7 and 15. CONCLUSION: By arterialization of the native liver, the regeneration of the small graft liver could be accomplished smoothly without metabolic burden. This animal model is useful for studying graft liver physiology of liver transplantation in preclinical setting. With this study, the first case of auxiliary partial orthotopic liver transplantation was performed successfully in the patients who suffered from metabolic liver disease.
Aorta
;
Female
;
Hemodynamics
;
Hepatectomy
;
Hepatic Artery
;
Hepatic Veins
;
Humans
;
Kidney
;
Liver Diseases
;
Liver Function Tests
;
Liver Regeneration
;
Liver Transplantation*
;
Liver*
;
Models, Animal
;
Physiology
;
Portal Vein
;
Proliferating Cell Nuclear Antigen
;
Regeneration
;
Renal Artery
;
Renal Veins
;
Swine
;
Tissue Donors
;
Transplants
;
Vena Cava, Inferior
;
Weights and Measures
6.Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis.
Kyoung Min MOON ; Gaeun KIM ; Soon Koo BAIK ; Eunhee CHOI ; Moon Young KIM ; Hyoun A KIM ; Mee Yon CHO ; Seung Yong SHIN ; Jung Min KIM ; Hong Jun PARK ; Sang Ok KWON ; Young Woo EOM
Clinical and Molecular Hepatology 2013;19(4):389-398
BACKGROUND/AIMS: We compared the cirrhosis-prediction accuracy of an ultrasonographic scoring system (USSS) combining six representative sonographic indices with that of liver stiffness measurement (LSM) by transient elastography, and prospectively investigated the correlation between the USSS score and LSM in predicting cirrhosis. METHODS: Two hundred and thirty patients with chronic liver diseases (187 men, 43 women; age, 50.4+/-9.5 y, mean+/-SD) were enrolled in this prospective study. The USSS produces a combined score for nodularity of the liver surface and edge, parenchyma echogenicity, presence of right-lobe atrophy, spleen size, splenic vein diameter, and abnormality of the hepatic vein waveform. The correlations of the USSS score and LSM with that of a pathological liver biopsy (METAVIR scoring system: F0-F4) were evaluated. RESULTS: The mean USSS score and LSM were 7.2 and 38.0 kPa, respectively, in patients with histologically overt cirrhosis (F4, P=0.017) and 4.3 and 22.1 kPa in patients with fibrotic change without overt cirrhosis (F0-F3) (P=0.025). The areas under the receiver operating characteristic (ROC) curves of the USSS score and LSM for F4 patients were 0.849 and 0.729, respectively. On the basis of ROC curves, criteria of USSS > or =6: LSM > or =17.4 had a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 89.2%:77.6%, 69.4%:61.4%, 86.5%:83.7%, 74.6%:51.9% and 0.83:0.73, respectively, in predicting F4. CONCLUSIONS: The results indicate that this USSS has comparable efficacy to LSM in the diagnosis of cirrhosis.
Adult
;
Area Under Curve
;
*Elasticity Imaging Techniques
;
Female
;
Hepatic Veins/physiopathology
;
Humans
;
Liver Cirrhosis/pathology/*ultrasonography
;
Male
;
Middle Aged
;
Odds Ratio
;
Predictive Value of Tests
;
Prospective Studies
;
ROC Curve
;
Severity of Illness Index
;
Spleen/anatomy & histology
;
Splenic Vein/physiology
7.Comparison of collateral circulation characteristics between Budd-Chiari syndrome and hepatitis B related liver cirrhosis with CT angiography.
Jin PENG ; Xiaodong WANG ; Weixia CHEN ; Dongsheng WU ; Acharya RIWAZ ; Zhenlin LI
Journal of Biomedical Engineering 2013;30(5):982-987
This study was aimed to investigate the imaging features of collateral circulation in Budd-Chiari syndrome (BCS) and hepatitis B related liver cirrhosis (LC) with multi-detector computed tomography (MDCT), and to discuss the value of MDCT in differential diagnosis of Budd-Chiari syndrome and hepatitis B related LC. Sixty cases of LC confirmed by medical history and laboratory examination and 15 cases of BCS proven by histopathology or ultrasonography were recruited in the present study. Morphological changes and anatomic characteristics were assessed with three dimensional (3D) vascular reconstruction of MDCT in all 75 cases. There were significantly more subjects with caudate lobe enlargement in BCS (11 cases, 73%) than in LC (5 cases, 8%). In BCS group, extrahepatic collateral circulation of ascending lumbar and azygous collateral pathways were found in 9 cases and epigastric varicose veins in 8 cases. Intrahepatic venous collaterals were documented in 12 cases combined with ascending lumbar and azygous vein collaterals in 9 cases and retroperitoneal varicose vein plexus in 6 cases. These intra- and extra-hepatic venous collaterals were not dectected in patients with LC. Morphological changes of the caudate lobe and the enhanced pattern of liver parenchyma were significantly different between patients with BCS and LC. Thus, it could be well concluded that contrast-enhanced CT scan and 3D CT angiography are very useful in differential diagnosis of BCS and LC.
Adult
;
Angiography
;
methods
;
Budd-Chiari Syndrome
;
diagnostic imaging
;
physiopathology
;
Collateral Circulation
;
physiology
;
Diagnosis, Differential
;
Female
;
Hepatic Veins
;
diagnostic imaging
;
Hepatitis B
;
complications
;
Humans
;
Liver Cirrhosis
;
diagnostic imaging
;
physiopathology
;
virology
;
Male
;
Middle Aged
;
Multidetector Computed Tomography
;
methods
;
Young Adult
8.Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease.
Won Ki HONG ; Kwang Yong SHIM ; Soon Koo BAIK ; Moon Young KIM ; Mee Yon CHO ; Yoon Ok JANG ; Young Shik PARK ; Jin HAN ; Gaeun KIM ; Youn Zoo CHO ; Hye Won HWANG ; Jin Hyung LEE ; Myeong Hun CHAE ; Sang Ok KWON
Journal of Korean Medical Science 2014;29(3):392-399
Tetrahydrobiopterin (BH4) is an essential cofactor in NO synthesis by endothelial nitric oxide synthase (eNOS) enzymes. It has been previously suggested that reduced intrahepatic BH4 results in a decrease in intrahepatic NO and contributes to increased hepatic vascular resistance and portal pressure in animal models of cirrhosis. The main aim of the present study was to evaluate the relationship between BH4 and portal hypertension (PHT). One hundred ninety-three consecutive patients with chronic liver disease were included in the study. Liver biopsy, measurement of BH4 and hepatic venous pressure gradient (HVPG) were performed. Hepatic fibrosis was classified using the Laennec fibrosis scoring system. BH4 levels were determined in homogenized liver tissues of patients using a high performance liquid chromatography (HPLC) system. Statistical analysis was performed to evaluate the relationship between BH4 and HVPG, grade of hepatic fibrosis, clinical stage of cirrhosis, Child-Pugh class. A positive relationship between HVPG and hepatic fibrosis grade, clinical stage of cirrhosis and Child-Pugh class was observed. However, the BH4 level showed no significant correlation with HVPG or clinical features of cirrhosis. BH4 concentration in liver tissue has little relation to the severity of portal hypertension in patients with chronic liver disease.
Adult
;
Aged
;
Biopterin/*analogs & derivatives/analysis
;
*Chromatography, High Pressure Liquid
;
Chronic Disease
;
Elasticity Imaging Techniques
;
Female
;
Hepatic Veins/physiology
;
Humans
;
Hypertension, Portal/complications/*diagnosis/metabolism
;
Liver/pathology
;
Liver Cirrhosis/ultrasonography
;
Liver Diseases/complications/*diagnosis/metabolism
;
Male
;
Middle Aged
;
Nitric Oxide/metabolism
;
Portal Pressure
;
Regression Analysis
;
Severity of Illness Index